(0:00 - 1:18) Diabetes. Heart disease. Cholesterol. Your doctor will run blood tests and frown over your results. Then they'll put you on medication to treat it. Unfortunately, everything doctors have been taught about the cause of these conditions is wrong. Statins used to treat high cholesterol are one of the most commonly prescribed drugs today, despite the fact that one of the listed side effects is an increased risk of diabetes. Clearly, drugs are not the answer. Ivor Cummins, who for many years now has been releasing very informative videos on social media platforms and at his website, thefatemperor.com, has interviewed some of the top experts in the world on these subjects. Not the experts that are promoted by pharmaceutical companies to market their products, but the real experts. Doctors and scientists who have nothing to gain from telling you the truth. And the good news is, there are simple things you can do to dramatically reduce your risk of heart disease and even reverse type 2 diabetes, as another guest on my show, Dr. Paul Marik, co-founder of the Frontline Critical COVID Care Alliance, did not long ago, after 20 years as a type 2 diabetic. (1:26 - 1:30) Ivor, it's a pleasure to have you back on the show. Great stuff, Will. Delighted to be back. (1:31 - 6:31) So, the last time we did an interview, it had nothing to do with health. We were talking about the globalist agenda, which you've also delved into at least as deeply as I have. But something that you have gone into even deeper than I have are things like diabetes, heart disease, the real causes of them. I want to talk about that today. I want to talk to you a little bit about and later on, we're going to get into a little bit of talking about mental resilience, mental health. But let's start with all of this stuff that people think they know about heart disease and diabetes and how it's just about all wrong. I'm just going to let you talk because you've interviewed many of the real experts on this. Yeah. I mean, back in 2015, I interviewed Dr. Joseph Kraft when he was 93 years old, and he did 15,000 insulin assays, full five-hour insulin measurements after people drank a 100 gram glucose drink. And he got incredible data. That was just one example. But what he found out was what we are aware of now, that even back in the 80s, type 2 diabetes was massively higher prevalence than people realized because they only call you a type 2 diabetic when your blood sugars go above 6.5 millimole or I think it's 125 in America milligrams. But he was finding if you measure insulin and he published a paper, the earliest laboratory diagnosis of diabetes, which uses his post glucose drink insulin measurements, and that actually catches way more people than the glucose. So by the time your glucose has gone off the track, you know, you've been diabetic for 10 to 20 years. Yeah. So he discovered this was huge and he did a little bit of work looking at cholesterol and he gave up because he just thought it was nonsense. And he was correct on that as well. So if we, if we go and look, well, Euro aspire, if we check out craft because craft says those with cardiac disease, not diagnosed with diabetes are simply undiagnosed. In other words, pretty much all heart disease comes from the vascular inflammatory condition of, you know, hyper insulinemia, insulin resistance. And that's pretty much most or nearly all of us. So that was the root cause. And we've discovered that's largely true. But one of the greatest studies was 2015 Euro aspire. And they went and they got around 7,000 people across 24 countries of Europe, ages 18 to 80, who were cardiac cases. So they looked across all the ages, all the countries, all the different genetics, and they said, okay, let's look closely at their blood glucose. And what they found was straight away, a third of these guys were type two diabetic on their medical record. Whoa. Okay. So that tells you something. However, they then look closely at their post glucose drink, glucose levels, OGTT, or oral glucose tolerance test. Now they didn't even measure insulin. Remember craft said you must measure insulin to catch all the guys. They only measured glucose, but they found another quarter were full blown type two diabetic undiagnosed. And another quarter were high risk for type two diabetes, but, but they were diabetic. They just didn't quite meet the high glucose for the threshold. So in other words, nearly three quarters of all the cardiac victims across Europe, all ages, all countries were type two diabetic. And they didn't measure insulin. And if they did, they would see, of course, what craft proved that you get way more. So he was correct. Nearly all cardiac disease, you know, vascular atherosclerosis disease, people have underlying diabetes. So that's kind of it. And the cholesterol, just to finish with it, we can talk more about cholesterol. Cholesterol is a great proxy or indirect indicator of hyperinsulinemia insulin resistance. So what the whole world did was they got a weak proxy. Um, it's good in some ways. If you look at the lipoproteins, you know, the ApoB and ApoA1 and the advanced cholesterol, that's a pretty good proxy for insulin resistance, but the old cholesterol is a weak one. So the whole world has been running round looking at a kind of a reflection, a weak reflection of the real root cause. And the reason they will never leave that is because there's billions and billions of dollars in cholesterol and pretty much jack in insulin. Right. And they doctors, you go to your doctor, you get these tests that comes back with high LDL, they put you on statins. And the thing that just blows me away is if you go, when you look at the information on statins, the manufacturers will tell you one possible side effect is an increased risk of diabetes. (6:32 - 7:10) Yeah. And it does because, well, it's complex, but it's connected to the insulin system. And if you screw with the cholesterol system, you indirectly promote higher insulin and, and there you go. But the really funny thing about the statins, um, I've been in the statin wars for many years, and it's quite funny. A British medical journal, a paper was published in 2016. And for the first time, really a team of doctors and analysts looked at all of the, or a whole selection of statin trials that were declared to be really successful. (7:11 - 7:48) And they said, well, we wonder what's the life extension for the average person with these drugs. You'd think someone would have asked it earlier. How much longer life can you expect for taking these drugs for three to five years? And they found out through using a graphical analysis that on average, I mean, some people might get an extension on average, it was three to four days of extra life over around five years. Now, you know, I know that's zero engineer. And statistically that is meaningless, meaningless. Yes. (7:49 - 8:18) And it was from the pharmaceutical company's own trials where they did run in periods and they took out loads of patients that were not ideal for their trials. So it was already biased. And it's three or four days. Yes. Something else I'd like you to, to just debunk is there isn't a misconception that, um, it's only overweight people who are in danger for diabetes. This of course is not true. (8:19 - 8:59) No, in, in some ways it's the opposite of true. And in some ways it's kind of true. The way it's kind of true is generally the overweight people generally are more insulin resistant. So they're more at risk of heart disease and type two diabetes, of course. But the problem is that many people genetically type two diabetes is actually the results you get when your body can't make more fat healthily. You know, it's the Dr. Ron Rosedale said type two diabetes is the price you pay for not being able to get fatter. (9:00 - 9:34) So what that means is if you look at lipodystrophy people and they've got a genetic condition, they're skinny as rakes. You can see their ribs. They look ripped. Okay. They can't make normal subcutaneous adipose tissue, normal fat. And the fat we have acts as a buffer for insulin and glucose. It's really important. It's an organ that's, you know, really important. So these lipodystrophy guys who are skinny as rakes, they're all type two diabetic, all of them. (9:35 - 10:09) So on the one hand, you've got fatter people are more likely to be insulin resistant. So they're broadly more likely, but the skinny guy or the Indian guy, Indians are famous for not getting fat. They just make a little belly, a little pot. They're nearly all diabetic, you know, right? Because they tend to just make visceral fat and a little pot belly. They go, they're diabetic, but they don't create the obesity around their whole body. But they're limited because they tend genetically not to make all body healthy fatness. (10:10 - 11:28) So they're a little bit like little bit like the lipodystrophy guys, but hopefully that explains it. It's very misleading. Waist to height ratio is the best measure. If you're going to look at fatness or appearance and risk for insulin resistance, diabetes, waist to height ratio, you measure your waist with your breath out or just normally around the belly button. Honestly, yeah, it's really easy to tuck it in. You measure around the belly button and you get your height to your waist and it should be two to one, which is practically no one in the world today in the West. Well, I, I it's interesting you bring that up a minus 0.43. So I very solidly in the healthy range, but then I've been a bodybuilder my whole life. So I do focus on keeping the fat down. So yeah, it's, it is, it's a, it's an, it's a probably the easiest indicator for anybody to do, but it's not the whole story. You can still have somebody who's got a healthy weights to height ratio that is diabetic and at risk of heart disease. And I've run into these people. I've talked to them where it's, and the real problem of course is diet. But before we get to the diet, I want to talk about the test from the many videos you have on your website that seems to be the most accurate. And that's the CAC score.